Press release

Swiss Takeover Board grants extension of the deadline to make a mandatory tender offer for SHL until 30 June 2018

Tel Aviv / Zurich March 21, 2018- SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions, announces that on 21 March 2018 the Swiss Takeover Board has taken the following decision 671/02 regarding a request for extension of the deadline to make a mandatory tender offer by Himalaya (Cayman Islands) TMT Fund, Himalaya Asset Management Ltd., Xiang Xu, Kun Shen, and Mengke Cai with respect to SHL:

  1. The deadline for Himalaya (Cayman Islands) TMT Fund, Himalaya Asset Management Ltd., Xiang Xu, Kun Shen, and Mengke Cai to make a tender offer to the shareholders of SHL Telemedicine Ltd. will be extended until 30 June 2018.
  2. This deadline extension is provided under the condition that Himalaya (Cayman Islands) TMT Fund, Himalaya Asset Management Ltd., Xiang Xu, Kun Shen and Mengke Cai inform the Takeover Board about the progress regarding the realization and the financing of the mandatory tender offer once every two weeks.
  3. The main motion, the subsidiary motion, and the motion of Nehama & Yoram Alroy Investment Ltd. and Elon Shalev to receive indemnification are rejected.
  4. SHL Telemedicine Ltd. is obliged to inform the public within two trading days about this decision on the approval of the deadline extension and to publish the orders of this decision.
  5. The Takeover Board publishes this decision on its website immediately after the publication according to para. 4 by SHL Telemedicine Ltd.
  6. The fee charged to Himalaya (Cayman Islands) TMT Fund, Himalaya Asset Management Ltd., Xiang Xu, Kun Shen, and Mengke Cai amounts to CHF 20'000.

Instruction on the Right to Appeal as per the decision:

Appeal (art. 140 of the Financial Market Infrastructure Act, SR 958.1):

This decision can be appealed within a period of five trading days with the Swiss Financial Market Supervisory Authority FINMA, Laupenstrasse 27, CH-3003 Bern. The appeal must be made in writing and must be substantiated. The appeal has to suffice the requirements of art. 52 of the Federal Act on Administrative Procedure.

For further information, please contact:

Martin Meier-Pfister, IRF Communications, phone: +41 43 244 81 40, shl@irfcom.ch

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit the web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.


Press release (PDF)



Provider
 Channel
 Contact
EQS Group Ltd., Switzerland
switzerland.eqs.com


 newsbox.ch
www.newsbox.ch


 Provider/Channel related enquiries
cs.switzerland@eqs.com
+41 41 763 00 50